NCT00267592 2016-05-19
Safety and Efficacy of Talampanel in Glioblastoma Multiforme
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
Clinical Trials
3 trialsNCT00064363 2012-03-08
Talampanel in Treating Patients With Recurrent High-Grade Glioma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00062504 2011-05-23
Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Terminated